| [1] | Uzoigwe C. E. and Ali O. (2022). Genetically modified porcine-to-human cardiac xenotransplantation. N. Engl. J. Med. 387:1337. DOI:10.1056/NEJMc2210401 |
| [2] | Montgomery R. A., Stern J. M., Lonze B. E., et al. (2022). Results of two cases of pig-to-human kidney xenotransplantation. N. Engl. J. Med. 386:1889−1898. DOI:10.1056/NEJMoa2120238 |
| [3] | He J., Shi J., Yang C., et al. (2025). Pig-to-human lung xenotransplantation into a brain-dead recipient. Nat. Med. 31:3388−3393. DOI:10.1038/s41591-025-03861-x |
| [4] | Mohiuddin M. M., Singh A. K., Corcoran P. C., et al. (2016). Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat. Commun. 7:11138. DOI:10.1038/ncomms11138 |
| [5] | Yamada K., Yazawa K., Shimizu A., et al. (2005). Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat. Med. 11:32−34. DOI:10.1038/nm1172 |
| Xu J., Yang F., Luo W., et al. (2025). Pig-to-human lung xenotransplantation: A pioneering step toward clinical reality. The Innovation Medicine 3:100174. https://doi.org/10.59717/j.xinn-med.2025.100174 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Historical milestones and key gene-editing strategies in lung xenotransplantation.